tropism testing facts challenges vision
play

Tropism Testing Facts Challenges Vision Arevir Meeting May 2011 - PowerPoint PPT Presentation

May 20, 2023 •342 likes •414 views

Tropism Testing Facts Challenges Vision Arevir Meeting May 2011 Therapy examples situation I: Therapy: Kaletra/AZT/3TC virus: wt after 1 year: PR: L63P RT: 41L, 215Y, 184V what to change? Who is out! Therapy

  1. Tropism Testing – Facts Challenges Vision Arevir Meeting May 2011

  2. Therapy examples • situation I: – Therapy: Kaletra/AZT/3TC virus: wt – after 1 year: PR: L63P RT: 41L, 215Y, 184V • what to change? • Who is out!

  3. Therapy examples • situation II: – Therapy: AZT/3TC/MVC; virus: wt, R5- tropic – after 1 year: RT: 41L, 215Y, X4-tropic • who is out and why ??

  4. Stability of Tropism under ART

  5. Resistance vs. Tropism shift • HIV exposure to drug selects for resistance = virus becomes non-responsive • After resistance selection: the affected drug is lost! • CCR5 antagonists select resistances within R5 ‐ tropic viruses! • Tropism shift under MVC therapy is NOT a “resistance”! = a selection mechanism for existing X4 ‐ tropic virus or for new virus evolution • X4 viruses emerge under insufficient backbone pressure! • Disappears when MVC is removed!(?)

  6. Challenges of R-Testing remain… (will we ever need it?)

Recommend

Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA M.

Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA M.

HIV Genotypischer Resistenzalgorithmus Deutschland Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA M. Obermeier 5/2012 Aims of the study Genotypic tropism testing from viral RNA is widely

259 views • 24 slides
Tropism Testing with XTrack C Heinz Stucki Institut fr med. Mikrobiologie Universitt Basel

Tropism Testing with XTrack C Heinz Stucki Institut fr med. Mikrobiologie Universitt Basel

Tropism Testing with XTrack C Heinz Stucki Institut fr med. Mikrobiologie Universitt Basel Introduction Genotyping: typically at amino acid level CTRPSNNTRKSIHIGPGRAFYTTGEIIGDIRQAHC e.g. 11/25 and G2P XTrack C : at nucleic acid

420 views • 12 slides
Tropism Testing Who needs a Phenotype Arevir Meeting May 2011 Swiss 3 step System

Tropism Testing Who needs a Phenotype Arevir Meeting May 2011 Swiss 3 step System

Tropism Testing Who needs a Phenotype Arevir Meeting May 2011 Swiss 3 step System Element 1 (TrackC): (ca. 85% of analyses) Element 2 (Geno2Pheno): -RNA-DNA conversion (cDNA); (ca. 25% of analyses) -PCR-amplification of V3 region

460 views • 9 slides
Coreceptor Tropism of HIV-1 Development of a virus-free Assay HIV-1 Tropism Study

Coreceptor Tropism of HIV-1 Development of a virus-free Assay HIV-1 Tropism Study

Update from the AREVIR-projects University of Cologne Institute of Virology Coreceptor Tropism of HIV-1 Development of a virus-free Assay HIV-1 Tropism Study Comparison of Trofile and Geno2pheno [coreceptor] Eva Heger Institute of

300 views • 13 slides
HIV- -1 tropism prediction 1 tropism prediction HIV Mattia CF Prosperi ahnven@yahoo.it

HIV- -1 tropism prediction 1 tropism prediction HIV Mattia CF Prosperi ahnven@yahoo.it

HIV- -1 tropism prediction 1 tropism prediction HIV Mattia CF Prosperi ahnven@yahoo.it University of Roma TRE Faculty of Computer Science Engineering Dept of Computer Science and Automation (DIA) via della vasca navale, 79 00149

279 views • 14 slides
The impact of APOBEC on the tropism of HIV Eva Heger AREVIR 09.05.2015 Eva Heger - The

The impact of APOBEC on the tropism of HIV Eva Heger AREVIR 09.05.2015 Eva Heger - The

The impact of APOBEC on the tropism of HIV Eva Heger AREVIR 09.05.2015 Eva Heger - The impact of APOBEC on the tropism of HIV - Tropism Coreceptor usage of HIV attachment to CD4 Coreceptor binding fusion gp41 gp120 V3 loop

783 views • 35 slides
HIV tropism assessment HIV tropism assessment HIV tropism assessment HIV tropism assessment

HIV tropism assessment HIV tropism assessment HIV tropism assessment HIV tropism assessment

HIV tropism assessment HIV tropism assessment HIV tropism assessment HIV tropism assessment using next generation sequencing using next generation sequencing using next generation sequencing using next generation sequencing Mattia CF Prosperi

783 views • 23 slides
HIV RESISTENCE/ HIV TROPISM AREV I R 2 0 1 8 S TA D T H OT E L A M R M E RT U R M , K L

HIV RESISTENCE/ HIV TROPISM AREV I R 2 0 1 8 S TA D T H OT E L A M R M E RT U R M , K L

HIV RESISTENCE/ HIV TROPISM AREV I R 2 0 1 8 S TA D T H OT E L A M R M E RT U R M , K L N 0 4 . 0 5 . M A I 2 0 1 8 Dr. Stefan Scholten In den RingColonnaden F I NANCI AL DI SCL OSURE Abbott/abbvie, BMS, Gilead, GSK,

1.17k views • 44 slides
HIV RESISTENCE/ HIV TROPISM AREV I R 2 0 1 9 S TA D T H OT E L A M R M E RT U R M , K L

HIV RESISTENCE/ HIV TROPISM AREV I R 2 0 1 9 S TA D T H OT E L A M R M E RT U R M , K L

HIV RESISTENCE/ HIV TROPISM AREV I R 2 0 1 9 S TA D T H OT E L A M R M E RT U R M , K L N 0 3 . 0 4 . M A I 2 0 1 9 Hauke Walter Dr. Joachim Bch Dr. Stefan Scholten In den RingColonnaden F I NANCI AL DI SCL OSURE

597 views • 43 slides
Internet Based Testing Testing 2.0 Background 750 000 4 000 1 : 400 Challenges

Internet Based Testing Testing 2.0 Background 750 000 4 000 1 : 400 Challenges

Examinations and Test Section Sep 2015 ATP- SIG (Dublin) Internet Based Testing Testing 2.0 Background 750 000 4 000 1 : 400 Challenges Austerity Application Growth 65% 300% Do more with less Opportunity Unproctored

501 views • 11 slides
Automated GUI Testing How to test an interactive application automatically Some GUI facts

Automated GUI Testing How to test an interactive application automatically Some GUI facts

Automated GUI Testing How to test an interactive application automatically Some GUI facts Software testing accounts for 50-60% of total software development costs AGUI2 Some GUI facts 2 Software testing accounts for 50-60% of total

676 views • 52 slides
Toxicity Testing in the 21 st Century: A Vision and Strategy Committee on Toxicity Testing and

Toxicity Testing in the 21 st Century: A Vision and Strategy Committee on Toxicity Testing and

Toxicity Testing in the 21 st Century: A Vision and Strategy Committee on Toxicity Testing and Assessment of Environmental Agents Board on Environmental Studies and Toxicology Institute for Laboratory Animal Research Division on Earth and Life

286 views • 14 slides
Automated GUI Testing How to test an interactive application automatically Some GUI facts

Automated GUI Testing How to test an interactive application automatically Some GUI facts

Automated GUI Testing How to test an interactive application automatically Some GUI facts Software testing accounts for 50-60% of total software development costs GUIs can constitute as much as 60% of the code of an application GUI

396 views • 27 slides
Risk-based Ship Design, Approval and Operation public presentation SAFEDOR facts Motivation and

Risk-based Ship Design, Approval and Operation public presentation SAFEDOR facts Motivation and

Risk-based Ship Design, Approval and Operation public presentation SAFEDOR facts Motivation and expected benefits SAFEDOR Vision and roadmap Challenges and expectations Outlook Created by Pierre C. Sames, Germanischer Lloyd SAFEDOR facts

140 views • 11 slides
Challenges and Opportunities in Mobile Testing Alessandra Gorla IMDEA Software Institute,

Challenges and Opportunities in Mobile Testing Alessandra Gorla IMDEA Software Institute,

Challenges and Opportunities in Mobile Testing Alessandra Gorla IMDEA Software Institute, Madrid, Spain Intro B.Sc. and M.Sc. in Milano-Bicocca, Italy Data-flow testing of Java Applications Contextual Integration Testing of Classes

1.71k views • 123 slides
Use of a genotypic assay for the prediction of HIV-1 co-receptor tropism and guiding the use of

Use of a genotypic assay for the prediction of HIV-1 co-receptor tropism and guiding the use of

Use of a genotypic assay for the prediction of HIV-1 co-receptor tropism and guiding the use of CCR5 antagonists in clinical practice Malcolm Macartney 1 , Jane Cameron 1 , Angela Strang 1 , Ana Garcia 1,2 , Clare Booth 1 , Neal Marshall 1 ,

167 views • 13 slides
Welcome APICS! + Overview Facts, Vision and Mission Portfolio, Markets and Capabilities The

Welcome APICS! + Overview Facts, Vision and Mission Portfolio, Markets and Capabilities The

Welcome APICS! + Overview Facts, Vision and Mission Portfolio, Markets and Capabilities The Internet of Your Things Quality and Certifications 2 2 Smartrac connect things 9/26/2019 9/26/2019 Key Facts High capacity manufacturing

690 views • 31 slides
Protect Your Health The facts about heart disease and stroke Heart & Stroke vision OUR VISION

Protect Your Health The facts about heart disease and stroke Heart & Stroke vision OUR VISION

Protect Your Health The facts about heart disease and stroke Heart & Stroke vision OUR VISION Healthy lives free of heart disease and stroke. Together, we will make it happen. 10% reduction in risk factors for 25% reduction in the death rate

638 views • 27 slides
Metropolitan Las Vegas Challenges, Opportunities, and a Vision University of Nevada Las Vegas

Metropolitan Las Vegas Challenges, Opportunities, and a Vision University of Nevada Las Vegas

Metropolitan Las Vegas Challenges, Opportunities, and a Vision University of Nevada Las Vegas Mark Muro and Robert Lang September 8, 2009 Why we are here Challenges and emerging opportunities A vision One reason is growth Metro Las Vegas

855 views • 48 slides
The Theory and Practice of Software Testing: Can we Test it? Yes we Can! Gregory M. Kapfhammer

The Theory and Practice of Software Testing: Can we Test it? Yes we Can! Gregory M. Kapfhammer

Software Testing Challenges Structural Testing Regression Testing Mutation Testing Future Work Conclusion The Theory and Practice of Software Testing: Can we Test it? Yes we Can! Gregory M. Kapfhammer Department of Computer Science

578 views • 23 slides
Discordant Tropism Determination for HIV-1 Isolates of CRF01_AE from Asia Wataru Sugiura 1 ,

Discordant Tropism Determination for HIV-1 Isolates of CRF01_AE from Asia Wataru Sugiura 1 ,

Discordant Tropism Determination for HIV-1 Isolates of CRF01_AE from Asia Wataru Sugiura 1 , Sverine Louvel 2 , Nico Pfeifer 3 , Masakazu Matsuda 2 , Yoshiyuki Yokomaku 2 , Rolf Kaiser 4 , Thomas Klimkait 5 rPhenotyping R5-tropic (TAK779)

211 views • 5 slides
European Clinical Data on HIV-1 Coreceptor Usage and Genotypic Identification of Tropism in HIV-2

European Clinical Data on HIV-1 Coreceptor Usage and Genotypic Identification of Tropism in HIV-2

European Clinical Data on HIV-1 Coreceptor Usage and Genotypic Identification of Tropism in HIV-2 Matthias Dring Max Planck Institute for Informatics May 8, 2015 Coreceptors are crucial for HIV-1 cell entry Delhalle et al, Int. J. Mol. Sci.

600 views • 17 slides
Conquering the Testing Challenges of Serverless Applications

Conquering the Testing Challenges of Serverless Applications

W2 DevOps & The Cloud Wednesday, October 2nd, 2019 11:30 AM Conquering the Testing Challenges of Serverless Applications Presented by: Peter Varhol

495 views • 31 slides
HIV-1 Tropism Arevir workshop Martin Obermeier Specialist for laboratory medicine

HIV-1 Tropism Arevir workshop Martin Obermeier Specialist for laboratory medicine

HIV-1 Tropism Arevir workshop Martin Obermeier Specialist for laboratory medicine Associate Medical center for infectious diseases Berlin Germany M. Obermeier 5/2013 Targets for HIV drug therapy plasma RNA proviral DNA Adapted

279 views • 26 slides

More recommend